Table 1.
Relationship between the clinical features and mean EpCAM + p75NTR+ or EpCAM + p75NTR− CTC counts in patients who received chemotherapy or chemoradiotherapy
| Characteristics | Number | EpCAM + p75NTR+ (average ± SD) | p value | EpCAM + p75NTR− (average ± SD) | p value |
|---|---|---|---|---|---|
| Male/female | 9/4 | 16.4 ± 19.7/14.0 ± 14.4 | 0.764 | 26.0 ± 34.9/13.3 ± 14.1 | 0.504 |
| Age ≥65/>65 | 5/8 | 22.8 ± 11.6/11.3 ± 11.9 | 0.114 | 38.2 ± 44.0/12.06 ± 11.7 | 0.131 |
| Ce-Ut/Mt-Ae | 2/11 | 19.0 ± 20.5/15.0 ± 12.2 | 0.666 | 2.0 ± 2.8/25.7 ± 31.4 | 0.325 |
| T 0–2/3–4 | 1/12 | 7.0/16.4 ± 13.0 | 0.501 | 0/23.9 ± 30.6 | 0.468 |
| N 0/1–3 | 1/12 | 7.0/16.4 ± 13.0 | 0.501 | 0/23.9 ± 30.6 | 0.468 |
| M 0/1 | 8/5 | 7.1 ± 5.9/29.4 ± 6.4 | *0.003 | 19.5 ± 20.8/26.2 ± 43.7 | 0.713 |
| Stages 1–2/3–4 | 1/12 | 7.0/16.4 ± 13.0 | 0.501 | 0/23.9 ± 30.6 | 0.468 |
CTC circulating tumor cell, SD standard deviation
*p < 0.05